Description

Favilow 400 Tablet is a medicine containing the active ingredient Favipiravir, which belongs to the antiviral class of medications. Favipiravir has been shown to inhibit the replication of RNA viruses, including influenza and certain strains of the novel coronavirus (SARS-CoV-2). Favilow 400 is indicated for the treatment of mild to moderate COVID-19 infection in adults. It is important to start Favilow 400 as early as possible after symptom onset, within the first few days of illness. Adverse effects like nausea, vomiting, gastrointestinal upset, and allergic reactions may occur, but they are generally well-tolerated.

Additional information